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Abstract
Objective: This study aimed to evaluate the effects of Azadirachta indica and Vernonia amygdalina 
extracts on the morphoanatomy of striated myofibrils in diabetic rat models.
Methodology: Thirty Wistar rats randomly assigned into 5 groups of 6 rats/group were used. Group A 
received distilled water only, B (herbal) received A. indica (500 mg/kg/day) and V. amygdalina (400 
mg/kg/day) simultaneously, C were diabetic rats, D were diabetic rats treated with herbal extracts 
combined and E, diabetic rats treated with metformin. Diabetes was induced with streptozotocin (70 
mg/kg). Muscles glutathione peroxidase (GPx) and blood glucose levels were determined. The rats were 
sacrificed at the end of 60days treatment. The quadriceps femoris muscle harvested for histology.
Results: Diabetic herbal treated rats became euglycemic by the end of 8 weeks. GPx activity was 
significantly (p<0.05) elevated compared to control. The histology of skeletal muscle fibers of the 
diabetic rats treated with herbal formulation and metformin showed minimal level of damage. 
Conclusions: The findings in this study showed that the herbal formulation could be used in treatment of 
diabetes and in ameliorating the associated muscular cytoarchitectural alterations.
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Résumé 
Objectif: Cette étude visait à évaluer les effets des extraits d'Azadirachtaindica et de Vernoniaamygdalina 
sur la morphoanatomie des myofibrilles striées dans des modèles de rats diabétiques.
Méthodes: Trente rats Wistar répartis au hasard en 5 groupes de 6 rats/groupe ont été utilisés. Le groupe A 
n'a reçu que de l'eau distillée, B (à base de plantes) a reçu A. Indica (500 mg/kg /jour) et V. amygdalina (400 
mg / kg / jour) simultanément, C rats werediabétique, D étaient des rats diabétiques traités avec des extraits 
de plantes combinés et E, des rats diabétiques traités avec de la metformine. Le diabète a été induit par la 
streptozotocine (70 mg/kg). Les muscles glutathion peroxydase (GPx) et la glycémie ont été déterminés. 
Les rats ont été sacrifiés à la fin du traitement de 60 jours. Le muscle quadriceps fémoral prélevé pour 
l'histologie.
Résultats: Les rats diabétiques traités aux herbes sont devenus euglycémiques au bout de 8 semaines. 
L'activité GPx était significativement (p <0,05) élevée par rapport au contrôle. L'histologie des fibres 
musculaires squelettiques des rats diabétiques traités avec une formulation à base de plantes et de la 
metformine a montré un niveau minimal de dommages.
Conclusion: Les résultats de cette étude ont montré que la formulation à base de plantes pouvait être 
utilisée dans le traitement du diabète et dans l'amélioration des altérations cytoarchitecturales musculaires 
associées.
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INTRODUCTION
Skeletal muscle tissue is the major amino 
acids reservoir in the body and plays an essential 
role in the regulation of nitrogen balance and 
glycemic homeostasis (1,2). Alongside increased 
proteolysis, the inability to repair damaged 
skeletal muscle is a characteristic feature of 
uncontrolled diabetes (3). In diabetes, the 
hyperglycemic condition is found to promote 
lipid peroxidation of low-density lipoprotein (by 
a superoxide-dependent pathway) resulting in 
free radicals' generation and therefore increased 
oxidative stress (4). The extra-cellular proteins, 
such as elastin, laminin and collagen are the 
major targets for these free radicals. They are first 
broken down into glycoproteins (due to the 
chronic hyperglycemia) and then further into 
fragments (5). These alterations in some tissues 
are associated with the development of 
c o m p l i c a t i o n s  s u c h  a s  c a t a r a c t s ,  
microangiopathy,  a theroscleros is  and 
nephropathy. 
Types 1 and 2 diabetes are characterized 
by a loss of insulin action in skeletal muscle, 
leading to changes in glucose and lipid 
metabolism, gene expression and protein 
phosphorylation (6). In type-2 diabetes in which 
cells do not respond to insulin many different 
drugs are developed taking into consideration 
possible disturbances in carbohydrate-
metabolism. The degradation of carbohydrates is 
inhibited, thereby reducing glucose absorption 
by the cells. To enhance glucose uptake by 
peripheral cells, biguanides such as metformin 
are used. Although several therapies are 
employed for treatment, there are certain 
limitations due to high cost and side effects (7,8). 
In the quest to proffer a lasting solution to this 
ominous and insidious disease, a pragmatic idea 
of using the combined effect of A. indica and V. 
amygdalina extract was developed to ameliorate 
and manage it (9). It has been proven that A. 
indica parts (especially, its leaves) have high 
efficacy in treating DM with no side effects. 
Similarly, studies conducted using streptozotocin 
(STZ)-induced diabetic animals showed that V. 
amygdalina administration decreased blood 
glucose by 50% compared to untreated diabetic 
animals (10). Since V. amygdalina has been a 
reliable treatment for various metabolic disorders 
(especially diabetes mellitus) and it is sumptuous, 
with highly nutritive and healing values, 
combining its leaves with other herbal extracts 
such as A. indica may enhance the management 
of DM when consumed. 
In the present study we investigated the 
anti-diabetic effects of combined herbal 
formulation of A. indica and V. amygdalina 
leaves in STZ-induced diabetic rat models. The 
work involved histological studies on skeletal 
muscle, as well as estimation of the antioxidant 




Thirty albino rats of Wistar strain (both 
sexes) were used in the study. The rats (8-10 
weeks old) weighing an average of 177 g were 
housed in wire gauze cages with alternating 12-hr 
natural light/dark cycles at room temperature in 
the animal house of the Department of Anatomy, 
University of Ilorin. They were fed with rat 
pellets and water ad libitum and were allowed to 
acclimatize for two weeks before beginning the 
experiment.
Botanical formula
The botanical formula consists of the 
leaves of A. indica and V. amygdalina as follows: 
V. amygdalina (400 mg/kg) and A. indica (500 
mg/kg) in the ratio 5:4. The crude extract of these 
herbs were prepared by soxhlet extraction using 
ethanol. The concentrations of the extract 
(diluted in distilled water) were prepared based 
on the rat's body weight and administered orally 
using an orogastric metal canula.
Procurement and taxonomy of the plants
Fresh leaves of A. indica (neem) were 
collected in the premises of the Department of 
Anatomy, University of Ilorin, Nigeria and that of 
V. amygdalina (bitter leaf) were collected at Oke-
odo area in Ilorin, Nigeria. Botanical 
identification was done at the Herbarium, 
Department of Botany, University of Ilorin. The 
samples collected were dried under shade, to 
protect the active constituents from destruction 
due to radiation, for a period of 3 weeks. After this 
period, the dried leaves were ground to fine 
powder and weighed using an analytical 
weighing balance (FA2104A, Gallenkomp, 
England).
Pharmacomathy of the extracts
Fresh leaves of A. indica and V. 
amygdalina were air-dried at room temperature. 
A total of 1690 g and 3076 g of V. amygdalina and 
A. indica respectively of the dry leaf powder was 
extracted after pounding and sieving the leaves. 
Thereafter, the powders of the two leaves were 
dissolved in 2 liters of 70% ethanol in different 
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containers overnight. After 3 days, the fluid was 
decanted and the filtrates were poured in beakers 
oand placed in the oven, regulated at 40 C (so that 
the active constituents are not denatured) for 
evaporation. It was later transferred into an 
evaporating dish. The evaporation was continued 
oat a temperature of 40 C until all the ethanol was 
gone leaving a greenish paste-like, extract of V. 
amygdalina and A. indica. Each of the extracts 
were kept separately and temporarily in 
oaluminum foil at a temperature of 4 C.
Treatment groups and experimental design
The animals were randomly assigned 
into 5 groups [A (Control), B (Herbal only), C 
(Diabetic), D (Diabetic + Herbal) and E (Diabetic 
+ Metformin)] (Table 1) of 6 (n=6) rats each. 
Rats in the control group were fed 4 ml distilled 
water/kg body weight [b.wt.]/day, those in Group 
B were treated with the herbal formulation 
comprising combined extracts of A. indica (500 
mg/kg b.wt./day) and V. amygdalina (400 mg/kg 
b.wt./day). Group C rats were induced diabetes 
using STZ (70 mg/kg b.wt.). Diabetes was also 
induced in rats in Groups D and E using STZ (as 
in Group C). Group D rats were subsequently 
treated with the herbal formulation as in Group B 
while Group E with Metformin at 350 mg/kg 
b.wt./day (11).
The dosages of the plant extracts were as 
determined from preliminary work in our 
laboratory.
Induction of diabetes and the placebo effect 
Diabetes was induced using STZ (Sigma, 
MO, USA) at 70 mg/kg b.wt. in 0.1 M citrate 
buffer at pH 4.5. It was injected intraperitoneally 
(i.p) to overnight fasted rats (12). The rats were 
allowed access to food and water after injection. 
Sustained hyperglycemia developed about 72-hr 
post-STZ injections. Rats with fasting blood 
glucose of ≥ 250 mg/dL were considered 
hyperglycemic (12). The non-diabetic (group A) 
and herbal treated (group B) rats received a single 
i.p injection of citrate buffer (1 ml/kg b.wt.) 
placebo of laboratory preparation.
Treatment duration 
Animals received the combined herbal 
formulation for 60 days. A. indica was given at 
500 mg/kg b.wt./day; V. amygdalina at 400 
mg/kg b.wt./day and metformin at 350 mg/kg 
b.wt./day for the same period. 
Blood glucose and body weight measurement
Blood glucose was measured in fasted 
rats at 9.00-10.00 h. using One Touch Ultra 2 
Glucometer and its strips (Lifescan, CA, USA). 
Blood was obtained from the dorsal vein of the 
tail (13). At day 0 of V. Amygdalina, A. indica and 
Metformin treatment, blood glucose was 
st rd th thmonitored every alternate hour (1 , 3 , 5  and 7  
h); then each day in the first week; and thereafter, 
twice in a week, for 8 weeks.
Body weights of the rats were taken prior to the 
induction of hyperglycemia, at day 0 of V. 
Amygdalina and A. indica treatments and on a 
daily basis thereafter, for 8 weeks, using a 
weighing balance.
Tissue homogenization
thAt the end of 60  day of treatment, the 
animals were euthanized under diethyl ether 
anesthesia and sacrificed. Laparotomy 
performed and blood collected from the inferior 
vena cava for protein analysis. Subsequently, the 
skeletal muscle (quadriceps femoris) were 
harvested and fixed in 40% formalin solution. A 
portion were also homogenized in phosphate 
buffer (0.1 M, pH 7.4), for the estimation of GPx. 
Muscle GPx activity was estimated by the 
method of Paglia and Valentrine (14), using the 
reagent kit from Randox Laboratories Ltd; 
(Antrim, U.K). The homogenate allowed to attain 
room temperature and 0.5 ml of drabkins solution 
was added to the homogenate. The timer was 
started simultaneously with the addition of R2; 
the spectrophotometer was blanked with distilled 
water. The initial absorbance of both the test and 
blank was read after 1 min and again after 1 and 2 
minutes at 340 nm. GPx = [change in abs/min x 
8412] u/L.
Tissue processing 
Part of the harvested skeletal muscle was 
fixed in Bouin's fluid and processed for 
histological studies. The muscle tissues were 
fixed in 10% formalin for 12 hours. It was then 
dehydrated, using ascending grades of alcohol, 
from 30% to absolute alcohol III; the tissue 
stayed about 2 hours in each grade of alcohol. 
Clearing was carried out overnight in xylene I for 
6 hours and in xylene II for 1 hour. It was then 
infiltrated with paraffin wax I and II for 30 
ominutes at 58-60 C followed by embedding with 
Leuchart's embedding boxes (2 L-shaped pieces 
of metal, usually brass). Sectioning was done 
with Leica's rotary microtome (Leica RM 2135, 
Germany) at 5 microns thickness adjustment. The 
tissues were mounted on slides using DPX as 
mountant, then stained via the normal procedure 
for Masson's trichrome stains which involved 
dissolving the ponceau 2R in 100 ml 1% acetic 
acid and the acid fuchsin in 50 ml acetic acid. 
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Light microscopic studies were carried out using 
an optical compound microscope (Uniscope, 
Japan).
Data analysis
Statistical analysis was carried out using 
Statistical Package for Social Sciences (SPSS) 
23.0 (SPSS Inc., Chicago, USA). Data were 
expressed as mean (± S.E.M). Means were 
compared using the student's t-test and p value < 
0.05 was considered significant.
Ethical considerations: All procedures in this 
investigation conformed to the guiding principles 
for research involving animals as recommended 
by the Declaration of Helsinki and the Guiding 
Principles in the Care and Use of Animals (15) 
and were approved by the Institutional 
Committee on the Use and Care of Animals in 
conformity with international acceptable 
standards.
RESULTS
At the end of experiment, diabetic group 
(group C) showed significant weight loss 
(104.8±17.03 g) compared to the control group 
(A group) (215.4±12.24 g; p < 0.05). There were 
no significant differences in the body weight 
between control and other groups: B - Herbal 
only (235.2±15.96 g), D - Diabetic+ Herbal 
(197.4±6.41 g) and E - Diabetic+ Metformin 
(244.7±29.84g) (Figure 1). 
The mean blood glucose concentrations were 
117.1±11.86 mg/dl in the control group, 
127.1±15.95 mg/dl in Herbal only, 446.7±66.86 
mg/dl in the Diabetic group, 293.0±57.17 mg/dl 
in Diabetic+ Herbal, and 226.3±44.64 mg/dl in 
Diabetic+ Metformin. The value in the diabetic 
group was significantly higher than in the control 
group (p < 0.05), while there were no significant 
differences between control and other groups 
(Figure 2).
The mean GPx enzyme activities were 
4327.5±26.87 IU/g in control, 4448.0±201.75 
IU/g in Herbal only, 2041.0±7.58 IU/g in 
Diabetic group, 3817.50±61.66 IU/g in 
Diabetic+ Herbal and 3621.50±209.66 IU/g in 
Diabetic+ Metformin, as illustrated in the bar 
chart (Figure 3). The value in the diabetic group 
was significantly less than in the control group 
(p<0.05), while there were also no marked 
significant differences in the mean enzyme 
activities between control and other groups.
In the light microscopic annotations, the diabetic 
group showed reduced number of nuclei, 
shrunken and indistinct fibers of the perimysium 
compared to control and herbal treated normal 
rats. The histology of the herbal and metformin 
treated diabetic rats were fairly similar to control 
(figure 4).
DISCUSSION
In a diabetic, carbohydrate diet usually 
stimulates the appetite center and disturbs energy 
balance (16). Weight loss resulting from 
intentional decrease in caloric intake (17-21) 
normalizes this imbalance, reduces insulin 
concentrations and favors utilization of stored fat 
as fuel in addition to reducing significantly 
insulin resistance (22) preventing the likely 
occurrence of diabetes. On the other hand, 
unintentional weight loss typified in diabetic 
subjects with impaired glucose metabolism does 
not achieve this goal of maintaining balance. The 
breakdown in muscle tissue, fluid loss 
( m i c t u r i t i o n )  a n d  d e h y d r a t i o n  f r o m  
hyperglycemia in addition to reduction in fat and 
lean mass that exacerbate risk of cachexia (23) 
are amongst the reasons for the unhealthy weight 
loss. Weight monitoring therefore is an indirect 
way of assessing responsiveness to management 
of diabetic patient using specific oral 
hypoglycemic regimens. In this study, the gross 
morphological body weight discrepancies in the 
animals were closely observed during the period 
of drug and herb (A. indica and V. amygdalina) 
administration. At the end of experiment 
increases in body weights were observed in all the 
groups except group C (diabetic group) which 
showed significant unintentional weight loss 
compared to control group (A group) (p<0.05). 
However, when the weight disparities in the 
diabetic rats treated with the herbal combination 
were compared to those treated with metformin, 
it revealed interesting alternating patterns. There 
were sharp increases (peaks) in mean weights on 
nd ththe 2  and 6  week followed by weight losses in 
the succeeding weeks (nadirs) in the metformin 
treated. This finding portrays aberrations in the 
glucose metabolic pathways in these rats (24). 
The herbal treated group on the other hand, had 
variations comparable to baseline control 
showing a better 'glucose handling capability'. 
Our finding is similar to previous work done by 
researchers using Acacia nilotica leaves extract 
(25). The increase in body weight is probably 
attributed to protein anabolic effect and reversal 
of gluconeogenesis and glycogenolysis by the 
improvement of insulin secretion as a result of 
insulinotropic effect (24) of our herbs and 
metformin.
Since oral hypoglycemic agents are 
substances that decrease the level of glucose in 
the blood and are used in the treatment of diabetes 
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2B) had a similar histological pattern as those of 
control treated with distilled water.
T h e  m a j o r  h i n d r a n c e  i n  t h e  
amalgamation of herbal medicine and modern 
medical practices is the lack of lucid 
scientific/clinical data proving their efficacy and 
safety. Therefore, in this present study there is the 
need to conduct further extensive research on the 
herbal formulation to develop simple bioassays 
for biological standardization and various animal 
models for toxicity and safety studies. It is also 
salient to establish the active components from 
these plant extracts. 
CONCLUSION
In conclusion, the findings have shown 
that combined A. indica and V. amygdalina herbal 
decoction has anti-diabetic effect in rats; hence it 
can be used in ameliorating the crippling disease. 
The herbal treated diabetic rats' maintained better 
morphology of skeletal myofibers, weight and 
antioxidant property compared to those treated 
wi th  met formin  a  convent ional  ora l  
hypoglycemic agent.
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Table 1: Experimental design 
 
Group batches: (n=30) No. of 
animals 
Treatment 
A: Non-diabetic (control) received a 
single intraperitoneal (i.p) injection of 




4 ml distilled water  
B: Herbal only received citrate buffer 
(as in A) 
 
6 
Herbal compound = V. amygdalina (400 
mg/kg b.wt. /day) and A. indica (500 mg/kg 
b.wt. /day) 
C: Diabetic (diabetic reference) Injected 
i.p streptozotocin (STZ) at 70 mg/kg 




4 ml distilled water 
 
D: Diabetic + Herbal 
 
6 
Injected STZ (as in C) and subsequently 
treated orally with herbal compound as in B 
 
E: Diabetic + Metformin 
 
6 
Injected STZ (as in C) and subsequently 




Figure 1: Changes in body weights of the rats from week 0 to week 8 . 
 
Values are expressed as Mean ± SEM; * p < 0.05 significantly different from control;
 
STZ: Streptozotocin induced diabetes; 
Groups:
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Figure 2: Blood glucose concentrations of the rats from week 0 to week 8 ; Values are expressed 
as Mean ± SEM; * p < 0.05 significantly different from control.
 



























































GLUTATHIONE PEROXIDASE (GPx) LEVELS IN EXPERIMENTAL AND CONTROL RATS
  
Figure 3: Muscle glutathione peroxidase (GPx) activities in experimental and control rats.   
Values are expressed as Mean ± SEM;* p < 0.05 significantly different from contro l. STZ: 
Streptozotocin induced diabetes; Groups:  [A (Control), B (Herbal only), C (Diabetic), D (Diabetic + 
Herbal) and E (Diabetic + Metformin)] 
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 PHOTOMICROGRAPHS  
Figure 4: Photomicrograph of the skeletal muscle.
 
Control (Group A, Plate 1A); Herbal only ( Group B, Plate 2 B); Diabetic/STZ induced rats (Group C, Plate 3 C); Diabetic/STZ induced and 
herbal treatment rats (Group D, Plate 4 D); Diabetic/STZ induced and metformin treatment rats (Group E, Plate 5 E). Masson’s trichrome 
stain; Magnification x 160;
 
the arrows indicate: Yellow:
 
(dense connective tissue epimysium); Black:
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